Intimate Networking & In-depth Learning, Catered for BD&L Professionals.
We bring together cross-functional experts from pharma, biotech and VCs to share best practices in due diligence, capital raising and M&A, licensing, and strategic alliance transactions.
With general BD&L sessions and two tracks dedicated to asset-based and platform/non-molecule-driven deals, attendees can customize their learning experience and gain insights that will help them unlock the potential of a deal and drive a company’s competitive position in the marketplace.
Key Topics Covered for BD&L
Deal Drivers and Investment Priorities for Big Pharma and VCs
Operating Models for Search and Evaluation to Advance Innovation
IP Due Diligence Issues that can Derail a Deal
Dealmaking Trends and Insights for New Modalities and Technologies
Alternative Deal Constructs and Creative Financing
Negotiating and Evaluating Platform Deals
Let's work together!
Find out why Fierce Pharma Engage is the right show for you.